| |
 |
|
Class Information
Number: 514/428
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6204286 |
Estrogen agonists/antagonists |
Mar. 20, 2001 |
| 6201016 |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
Mar. 13, 2001 |
| 6197773 |
N-acyl and N-aroyl aralkyl amides as serotonergic agents |
Mar. 6, 2001 |
| 6197789 |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
Mar. 6, 2001 |
| 6190695 |
Pharmaceutical composition containing osteogenesis-promoting substance |
Feb. 20, 2001 |
| 6187806 |
N-linked sulfone of heterocyclic thioester hair growth compositions and uses |
Feb. 13, 2001 |
| 6187807 |
Methods of use and compositions of (S) (-)-amisulpride |
Feb. 13, 2001 |
| 6184244 |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
Feb. 6, 2001 |
| 6180658 |
Method for counteracting blood platelet aggregation in a patient in need thereof |
Jan. 30, 2001 |
| 6180133 |
Antioxidant composition for topical/transdermal prevention and treatment of wrinkles |
Jan. 30, 2001 |
| 6174898 |
Method of treating filariae |
Jan. 16, 2001 |
| 6174923 |
Use of ethynyl alanine amino diol compounds for treatment of renin-mediated disorders |
Jan. 16, 2001 |
| 6172064 |
Formamides as therapeutic agents |
Jan. 9, 2001 |
| 6172117 |
Biocidal preservatives |
Jan. 9, 2001 |
| 6166015 |
Pyrrolidine derivatives-CCR-3 receptor antagonists |
Dec. 26, 2000 |
| 6166063 |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
Dec. 26, 2000 |
| 6159995 |
Substituted diaminocarboxylic acids |
Dec. 12, 2000 |
| 6159989 |
Antagonists of gonadotropin releasing hormone |
Dec. 12, 2000 |
| 6160018 |
Prophylactic composition and method for alzheimer's Disease |
Dec. 12, 2000 |
| 6160010 |
BTK inhibitors and methods for their identification and use |
Dec. 12, 2000 |
| 6153624 |
Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
Nov. 28, 2000 |
| 6143776 |
Tosylproline analogs as thymidylate synthase inhibitors |
Nov. 7, 2000 |
| 6140315 |
Therapeutic uses of goserelin acetate |
Oct. 31, 2000 |
| 6136847 |
Water-soluble trioxanes as potent and safe antimalarial agents |
Oct. 24, 2000 |
| 6133303 |
Bicyclic inhibitors of protein farnesyl transferase |
Oct. 17, 2000 |
| 6132774 |
Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
Oct. 17, 2000 |
| 6133262 |
Antithrombotic agents |
Oct. 17, 2000 |
| 6130242 |
S-procyclidine for treating urinary incontinence |
Oct. 10, 2000 |
| 6124346 |
Estrogen agonist/antagonists treatment of atherosclerosis |
Sep. 26, 2000 |
| 6124361 |
Bicyclo[3.1.0]hexanes and related compounds |
Sep. 26, 2000 |
| 6110959 |
Carboxylic acid derivatives having fused rings |
Aug. 29, 2000 |
| 6110944 |
LTA.sub.4, hydrolase inhibitors |
Aug. 29, 2000 |
| 6107331 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
Aug. 22, 2000 |
| 6093733 |
Muscarinic receptor agonists |
Jul. 25, 2000 |
| 6077863 |
2-aryl-4-halo-5-(trifluoromethyl)pyrrole-3-carbonitriles for the protection of wood, wood products and wooden structures from insect attack |
Jun. 20, 2000 |
| 6075023 |
Method for combatting fish mycoses and one-celled ectoparasites |
Jun. 13, 2000 |
| 6071970 |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Jun. 6, 2000 |
| 6069175 |
Estrogen agonist/antagonists treatment of atherosclerosis |
May. 30, 2000 |
| 6069165 |
Pharmaceutical compositions containing amisulpride and their therapeutic applications |
May. 30, 2000 |
| 6060504 |
N-methyl-N-[(1S)-1-phenyl-2-(3S)-hydroxypyrrolidin-1-yl)ethyl]-2 -2-diphenylacetamide |
May. 9, 2000 |
| 6060503 |
Benzopyran-containing compounds and method for their use |
May. 9, 2000 |
| 6057358 |
Amine derivatives, processes for producing them and a use of them as antiarrhythmic drugs |
May. 2, 2000 |
| 6057342 |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
May. 2, 2000 |
| 6057322 |
Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
May. 2, 2000 |
| 6051598 |
Amino ceramide-like compounds and therapeutic methods of use |
Apr. 18, 2000 |
| 6051573 |
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists |
Apr. 18, 2000 |
| 6040332 |
Amino ceramide-like compounds and therapeutic methods of use |
Mar. 21, 2000 |
| 6037363 |
Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
Mar. 14, 2000 |
| 6037370 |
Methods and compositions for stimulating neurite growth |
Mar. 14, 2000 |
| 6034102 |
Atherosclerosis treatment |
Mar. 7, 2000 |
|
|
|
